Tutogen Medical

Tutogen Medical, Inc., a Florida corporation, was formed in 1985 and with its consolidated subsidiaries (collectively, the “Company” or “Tutogen”, develops, manufactures and markets sterile biological implant grafts made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast® Process of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in dental, spinal, urology, ophthalmology, head and neck, and general surgery procedures. One of the Company's wholly owned subsidiaries, Tutogen Medical GmbH, designs, develops, processes, manufactures, markets, and distributes specialty surgical grafts and services to over 20 countries through a worldwide distribution network. Another subsidiary, Tutogen Medical (United States), Inc., was formed in 1994 to process, market and distribute allografts for the U.S. market. The Company's worldwide corporate headquarters is located in Alachua, Florida.The Company has a manufacturing facility in Alachua, Florida, as well as international executive offices, processing and manufacturing facilities in Neunkirchen, Germany, and a sales office in Boulogne, France.

Contact Details: 13709 Progress Blvd. Box 19 Alachua NJ 32615 United States of America Tel: 386-462-0402 Fax: 386-462-1421 Email: CustomerService@Tutogen.com WWW: www.tutogen.com/

Loading...

Press Releases on Tutogen Medical:
Despite the Economic Downturn, Long-Term Growth Potential in the US Dental Biomaterial Market Remains Robust	4th May, 2009	Millennium Research Group	Millennium Research Group releases latest editions of its Industry Quarterly publications focused on recent events in the cardiovascular, endoscopy, orthopedics, aesthetics, and imaging and healthcare
How Long Will the Economic Downturn Affect the Dental Biomaterials Market?	24th March, 2009	Millennium Research Group	Despite minimal growth in 2009, the US dental biomaterials market will rebound to reach upwards of $230 million by 2013, according to Millennium Research Group WALTHAM, Mass., March 24 /PRNewswire/ -

BioNews Results for Tutogen Medical:
RTI Biologics Announces 2009 Third Quarter Results	SmartBrief:  Oct 28 2009 2:45PM Matching: tutogen medical
RTI Biologics Announces 2009 Third Quarter Results	Genetic Engineering News:  Oct 28 2009 1:34PM Matching: tutogen medical
RTI Biologics revenues increases to $42.8 million in third quarter 2009	News-Medical.Net:  Oct 28 2009 12:51PM Matching: tutogen medical
Ascension Orthopedics Appoints Guy L. Mayer as New CEO	Freshnews.com:  Oct 20 2009 1:14PM Matching: tutogen medical

Tutogen Medical Patents:
US Patent No.	Title
7060096	Implant consisting of bone material
7018413	Modular system for spinal column fusion
6988015	Bone implant
6942961	Method for dehydrating biological tissue for producing preserved transplants
6379385	Implant of bone matter
→View more Tutogen Medical patents.

Tutogen Medical (TTG) Financial information Links from Barchart
TTG Quote from from Barchart.com
TTG Chart from from Barchart.com
TTG Profile from from Barchart.com
TTG Opinion from from Barchart.com
→View more Tutogen Medical finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1313 times since April 2007, the link to the organisation's website has been followed 192 times

Recent Search Terms used to find this page: tutogen allograft | how was tutogen formed | tutogen allograft | TUTOGEN LINK | Tutogen Medical | TUTOGEN | tutogen allograft | tutogen allograft | Tutogen Medical GmbH | tutogen | .

Search for more companies in Alachua

Search for more companies in NJ

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Tutogen Medical